Mark Hueppelsheuser | executive |
Daniel Virnich | executive |
Mihir Shah | executive |
Jack Slevin | analyst |
Good afternoon, and welcome to The Oncology Institute's Fourth Quarter 2023 and Full Year 2023 Earnings Conference Call. Today's call is being recorded. [Operator Instructions] At this time, I'd like to turn the conference over to Mark Hueppelsheuser, General Counsel at TOI. Thank you.
You may begin.